Abstract:We have used a highly uncontrolled cohort to validate some of the important pathways in aging and shown that routine untargeted measurements are a valuable resource in population‐wide studies of metabolomic biomarkers. The feature selection returned known biomarkers that strongly associate with inflammaging, the link between inflammation and aging. We also identified a new metabolite, cyclo (leu‐pro) which is not endogenous but plays antimicrobial and antiviral roles. Untargeted metabolomics is the study of all detectable small molecules, and in geroscience, metabolomics has shown great potential to describe the biological age—a complex trait impacted by many factors. Unfortunately, the sample sizes are often insufficient to achieve sufficient power and minimize potential biases caused by, for example, demographic factors. In this study, we present the analysis of biological age in ~10,000 toxicologic routine blood measurements. The untargeted screening samples obtained from ultra‐high pressure liquid chromatography‐quadruple time of flight mass spectrometry (UHPLC‐ QTOF) cover + 300 batches and + 30 months, lack pooled quality controls, lack controlled sample collection, and has previously only been used in small‐scale studies. To overcome experimental effects, we developed and tested a custom neural network model and compared it with existing prediction methods. Overall, the neural network was able to predict the chronological age with an rmse of 5.88 years (r2 = 0.63) improving upon the 6.15 years achieved by existing normalization methods. We used the feature importance algorithm, Shapley Additive exPlanations (SHAP), to identify compounds related to the biological age. Most importantly, the model returned known aging markers such as kynurenine, indole‐3‐aldehyde, and acylcarnitines along with a potential novel aging marker, cyclo (leu‐pro). Our results validate the association of tryptophan and acylcarnitine metabolism to aging in a highly uncontrolled large‐s cale sample. Also, we have shown that by using robust computational methods it is possible to deploy large LC‐MS datasets for metabolomics studies to reduce the risk of bias and empower aging studies.

A metabolomic signature of decelerated physiological aging in human plasma

Phenotypic Age: a novel signature of mortality and morbidity risk

Markers of aging: Unsupervised integrated analyses of the human plasma proteome

Metabolic Age Based on the BBMRI-NL 1H-NMR Metabolomics Repository as Biomarker of Age-related Disease

A molecular index for biological age identified from the metabolome and senescence‐associated secretome in humans

Metabolite signatures of chronological age, aging, survival, and longevity

Large‐Scale metabolomics: Predicting biological age using 10,133 routine untargeted LC–MS measurements

Precise Metabolomics Reveals a Diversity of Aging-Associated Metabolic Features

Undulating changes in human plasma proteome profiles across the lifespan

Determinants of accelerated metabolomic and epigenetic aging in a UK cohort

A lipidomic based metabolic age score captures cardiometabolic risk independent of chronological age

Untargeted metabolomics for uncovering biological markers of human skeletal muscle ageing

Epigenetic and Metabolomic Biomarkers for Biological Age: A Comparative Analysis of Mortality and Frailty Risk

The metabolic footprint of aging in mice

Plasma acylcarnitines and gut‐derived aromatic amino acids as sex‐specific hub metabolites of the human aging metabolome

Plasma triacylglycerol length and saturation level mark healthy aging groups in humans

Machine learning and data-driven inverse modeling of metabolomics unveil key process of active aging

A metabolomic profile of biological aging in 250,341 individuals from the UK Biobank

Proteomics in aging research: A roadmap to clinical, translational research

The association of circulating bioenergetic metabolites with healthy human aging

A toolkit for quantification of biological age from blood chemistry and organ function test data: BioAge